Role of Kasahara Dashemani Vati in Kasa and Vyadhikshamatva in children with special reference to recurrent respiratory tract infections
Journal name: AYU (Journal of Research in Ayurveda)
Original article title: Role of Kasahara Dashemani Vati in Kasa and Vyadhikshamatva in children with special reference to recurrent respiratory tract infections
AYU is an internationally recognized quarterly journal dedicated to advancing research in Ayurveda. The journal covers a wide range of topics, including clinical and pharmacological research in Ayurveda's eight branches, herbal remedies, phytochemistry, and ethnomedicine.
Original source:
This page is merely a summary which is automatically generated hence you should visit the source to read the original article which includes the author, publication date, notes and references.
Nayan Kumar Subrahmanya
Kalpana Shanthibhai Patel
Virendra Kumar Kori
Rajagopala Shrikrishna
Download the PDF file of the original publication
AYU (Journal of Research in Ayurveda):
(An International Quarterly Journal of Research in Ayurveda)
Full text available for: Role of Kasahara Dashemani Vati in Kasa and Vyadhikshamatva in children with special reference to recurrent respiratory tract infections
Year: 2013 | Doi: 10.4103/0974-8520.123124
Copyright (license): CC BY-NC-SA 4.0
Summary of article contents:
The present single-centered randomized control trial (RCT) was carried out with the prime aim of assessing the effect of Kasahara Dashemani Vati (trial drug) on Kasa and Vyadhikshamatva in the children suffering from recurrent respiratory tract infections and comparing it with the efficacy of Indukanta Vati. The clinical trial included 40 patients belonging to age group of 3-12 years. The drugs were administered in a daily dose fixed as per “Clark's Rule” along with honey for duration of 60 days. The effect of treatment on the signs and symptoms of Kasa was assessed on the 15th day, whereas the effect on Vyadhikshamatva was assessed on the 60th day. The patients were under follow-up for a period of 60 days after completing the treatment course for evaluation of any recurrence. Effect of the therapy on the individual signs and symptoms of Kasa, laboratory parameters, immunoglobulin (Ig) biomarkers, status of Atura Bala, and prevention of recurrence during follow-up period were the parameters used to assess the overall effect of therapy. The observed data were subjected to appropriate statistical analysis for testing the statistical significance. Kasahara Dashemani provided relief in all symptoms of Kasa irrespective of Doshic involvement and on the parameters of Atura Bala. All the changes were statistically highly significant. The control group also showed similar effects which were statistically highly significant. The trial group was found to have a direct influence on serum Ig status. No patient has reported any adverse drug reactions during the treatment and follow-up periods. Keywords: Immunoglobulin, Indukanta Vati, Kasahara Dashemani Vati, Recurrent respiratory tract infection, Vyadhikshamatva
Other Health Sciences Concepts:
Discover the significance of concepts within the article: ‘Role of Kasahara Dashemani Vati in Kasa and Vyadhikshamatva in children with special reference to recurrent respiratory tract infections’. Further sources in the context of Health Sciences might help you critically compare this page with similair documents:
Kasa, Vyadhikshamatva, Signs and symptoms, Clinical trial, Statistical Significance, Adverse drug reaction, Follow Up Period, Effect of treatment, Pediatric age group, Randomized control trial, Atura Bala, Laboratory parameters, Vataja symptoms, Kaphaja symptoms, Kasa disease, Pediatric OPD, Doshic involvement, Statistically highly significant, Kasa treatment, Recurrent Respiratory Tract Infection, Immunomodulatory drug.